Search
Friday 24 July 2015
  • :
  • :
Latest Update

Active Stocks News Alert: Duke Energy Corp (NYSE:DUK), Danaher Corporation (NYSE:DHR), Sanofi SA (ADR) (NYSE:SNY), PepsiCo, Inc. (NYSE:PEP)

On Tuesday, Shares of Duke Energy Corp (NYSE:DUK), lost - 1.16% to $72.42.

Duke Energy Renewables, declared it has attained a 20-megawatt (MW) AC solar power project in Shawboro, N.C., from Ecoplexus Inc., lead developer of the project.

“We are happy to add a quality project from Ecoplexus to our growing solar portfolio in Eastern North Carolina,” said Greg Wolf, Duke Energy president, Commercial Portfolio. “Providing clean, renewable energy and opportunities for local economic development in the state are important to the company.”

Duke Energy Corporation, together with its auxiliaries, operates as an energy company in the United States and Latin America. It operates through three segments: Regulated Utilities, International Energy, and Commercial Power.

Shares of Danaher Corporation (NYSE:DHR), declined - 0.89% to $87.79, during its last trading session.

Danaher Corporation, declared he final proration factor of 83.2431 percent in its split-off exchange offer for Danaher common stock in connection with the formerly declared separation of Danaher’s Communications business and merger of Potomac Holding LLC, the Danaher partner holding Danaher’s Communications business, with a partner of NetScout Systems, Inc. (NTCT). The merger of Potomac Holding LLC and a partner of NetScout was accomplished on July 14, 2015.

A total of 31,248,537 shares of Danaher common stock were validly tendered (and not withdrawn) in the exchange offer, counting 175,603 shares tendered by odd-lot shareholders (not taking into account plan participants in Danaher savings plans). Such odd-lot shareholders were not subject to proration, and their shares were fully accepted in the offer. The remaining validly tendered shares of Danaher common stock were accepted in the exchange on a pro rata basis using the final proration factor. Shares of Danaher common stock that were validly tendered but not accepted for exchange will be returned to tendering shareholders.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company’s Test & Measurement segment provides test, measurement, and monitoring products that are used in electronic design, manufacturing, and technology development; hardware and software solutions to deploy, manage, and secure communication network technologies and services; and tools, toolboxes, and automotive maintenance equipment.

At the end of Tuesday’s trade, Shares of Sanofi SA (ADR) (NYSE:SNY), lost - 0.49% to $52.99.

Sanofi, has launched a new campaign to assist break family cycles of early heart disease and death from Familial Hypercholesterolaemia (FH). Heart of the Family aims to enhance awareness of FH to encourage earlier diagnosis and testing of family members as prompt diagnosis and appropriate treatment can assist save lives.

FH is a treatable, genetic condition characterised by abnormally high cholesterol levels from birth, which affects about 1 in 500 people in the UK; about the same number of children and young people under 19 years old are affected by type 1 diabetes.[2],[3] However, 85% of people with FH remain undiagnosed and untreated, putting them at raised risk of premature heart disease and death.[2],[4] A new online survey of 150 UK GPs, commissioned by Sanofi, shows that two out of five (39%) under-estimated the prevalence of FH and a further third (33%) recognise that there is a need for raised awareness among GPs.

Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, counting Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-1 receptor agonist; and Afrezza, an inhaled insulin to improve glycemic control, in addition to Toujeo, an insulin glargine.

Finally, PepsiCo, Inc. (NYSE:PEP), ended its last trade with -0.39% loss, and closed at $96.93.

PepsiCo, declared a quarterly dividend of $0.7025 per share of PepsiCo common stock, a 7.3 percent enhance as compared to the comparable year-earlier period. The dividend is payable on September 30, 2015 to shareholders of record as of September 4, 2015. PepsiCo has paid successive quarterly cash dividends since 1965, and 2015 marks the company’s 43rd successive annual dividend enhance.

Over the past ten years, PepsiCo has returned over $63 billion to shareholders in the form of dividends and share repurchases. The company anticipates to return $8.5 to $9 billion to shareholders in the form of dividends and share repurchases in 2015.

PepsiCo, Inc. operates as a food and beverage company worldwide. Its Frito-Lay North America segment offers Lay’s potato chips, Doritos tortilla chips, Cheetos cheese-flavored snacks, Tostitos tortilla chips, branded dips, Ruffles potato chips, Fritos corn chips, and Santitas tortilla chips.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *